Treatment strategies for hemoglobin E beta-thalassemia

Blood Reviews

Volumn 26, Issue SUPPL.1, 2012, Pages

  Olivieri, Nancy F ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Anemia; Beta thalassemia; Hemoglobin E; Iron chelation therapy; Splenectomy; Transfusion

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN E; IRON CHELATING AGENT;

ANEMIA; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; GENOTYPE; HEMOGLOBIN E BETA THALASSEMIA; HEREDITY; HUMAN; INFECTION; IRON OVERLOAD; MALARIA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT;

BETA-THALASSEMIA; BLOOD TRANSFUSION; HEMOGLOBIN E; HUMANS; IRON CHELATING AGENTS; SPLENECTOMY;

EID: 84861377859     PISSN: 0268960X     EISSN: 15321681     Source Type: Journal    
DOI: 10.1016/S0268-960X(12)70009-7     Document Type: Article

References (18)

1. Weatherall DJ The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010, 115(22):4331-4336.
2. Olivieri NF, Pakbaz Z, Vichinsky E HbE/beta-thalassemia: basis of marked clinical diversity. Hematol Oncol Clin North Am 2010, 24(6):1055-1070.
3. Lorey F, Cunningham G, Vichinsky EP, et al. Universal newborn screening for Hb H disease in California. Genet Test 2001, 5(2):93-100.
4. Orkin SH, Kazazian HH, Antonarakis SE, Ostrer H, Goff SC, Sexton JP Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature 1982, 300(5894):768-769.
5. Weatherall DJ, Clegg JB The Thalassemia Syndromes 2001, Blackwell Science, Oxford. 4th ed.
6. de Silva S, Fisher CA, Premawardhena A, et al. Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations. Sri Lanka Thalassaemia Study Group. Lancet 2000, 355(9206):786-791.
7. Premawardhena A, Fisher CA, Olivieri NF, et al. Haemoglobin E beta thalassaemia in Sri Lanka. Lancet 2005, 366(9495):1467-1470.
8. Sripichai O, Makarasara W, Munkongdee T, et al. A scoring system for the classification of beta-thalassemia/Hb E disease severity. Am J Hematol 2008, 83(6):482-484.
9. Nuinoon M, Makarasara W, Mushiroda T, et al. A genome-wide association identified the common genetic variants influence disease severity in beta0-thalassemia/hemoglobin E. Hum Genet 2010, 127(3):303-314.
10. Olivieri NF, Muraca GM, O'Donnell A, Premawardhena A, Fisher C, Weatherall DJ Studies in haemoglobin E beta-thalassaemia. Br J Haematol 2008, 141(3):388-397.
11. Winichagoon P, Thonglairoam V, Fucharoen S, Wilairat P, Fukumaki Y, Wasi P Severity differences in beta-thalassaemia/haemoglobin E syndromes: implication of genetic factors. Br J Haematol 1993, 83(4):633-639.
12. Premawardhena A, Fisher CA, Fathiu F, et al. Genetic determinants of jaundice and gallstones in haemoglobin E beta thalassaemia. Lancet 2001, 357(9272):1945-1946.
13. Olivieri NF, De Silva S, Premawardena A, et al. Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia. J Pediatr Hematol Oncol 2000, 22(6):593-597.
14. Olivieri N, Thayalasuthan V, Muraca G, et al. Rates of non-transfusional iron accumulation in Hb E thalassemia. 52nd American Society of Hematology Annual Meeting, Orlando, Florida. Abstract 5147.
15. O'Donnell A, Premawardhena A, Arambepola M, et al. Interaction of malaria with a common form of severe thalassemia in an Asian population. Proc Natl Acad Sci U S A 2009, 106(44):18716-18721.
16. O'Donnell A, Premawardhena A, Arambepola M, et al. Age-related changes in adaptation to severe anemia in childhood in developing countries. Proc Natl Acad Sci U S A 2007, 104(22):9440-9444.
17. Lok CY, Merryweather-Clarke AT, Viprakasit V, et al. Iron overload in the Asian community. Blood 2009, 114(1):20-25.
18. Andrews NC Forging a field: the golden age of iron biology. Blood 2008, 112(2):219-230.